Together with our sister company, SITES Medical, we formed our high velocity, single-piece flow manufacturing process by developing and connecting key enabling technologies that produce a single implant as efficiently as batch or continuous processing. These enabling technologies are described below and provide game-changing cost and inventory savings along with substantial time-to-market reductions. Though the greatest value comes from the combination of these technologies, OEMs can also elect to leverage a sub-set of the technologies that fit their organizational goals.
By using oversized, generic castings and forgings there is no need to develop casting or forging tools for every SKU, reducing time-to-market by 4 to 12 months. Individual SKU castings or forgings can be developed after product launch or whenever it provides an appropriate cost advantage.
Applying our proprietary Dimensional Stabilization process to CoCr and Ti components greatly reduces part movement during manufacturing, thereby eliminating the need for manual re-work and allowing process validation and automation, including zero set up time.
Proprietary technology offers improved implant-bone attachment without the risks or high costs of other materials and facilitates high velocity manufacturing. This platform technology has broad orthopedic applications.
Our design transfer to manufacturing process is automated through the use of a comprehensive digital twin of the manufacturing process, reducing time-to-market by 6 to 15 months.
A fully integrated, dedicated process flow with zero setup, common fixturing, automated transfer and digital inline inspection enables single-piece order manufacturing.
The Design History Record will have all elements required by regulators plus a complete scan of the manufactured product.